{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T11:37:03Z","timestamp":1782819423144,"version":"3.54.5"},"publisher-location":"Dordrecht","reference-count":38,"publisher":"Springer Netherlands","isbn-type":[{"value":"9789402410778","type":"print"},{"value":"9789402410792","type":"electronic"}],"license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017]]},"DOI":"10.1007\/978-94-024-1079-2_95","type":"book-chapter","created":{"date-parts":[[2017,8,28]],"date-time":"2017-08-28T04:54:12Z","timestamp":1503896052000},"page":"1191-1201","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Protective Effect of Taurine on Mice with Doxorubicin-induced Acute Kidney Injury"],"prefix":"10.1007","author":[{"given":"Yon-Suk","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-Heung","family":"Sung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujiao","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun-Ju","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Jin","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Joung","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pyo-Jam","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun-Kyung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"95_CR1","first-page":"1108","volume":"61","author":"EK Abbas","year":"2011","unstructured":"Abbas EK (2011) Histopathological changes caused by doxorubicin in laboratory mice (Mus musculus L). J Park Med Assoc 61:1108\u20131110","journal-title":"J Park Med Assoc"},{"issue":"2","key":"95_CR2","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1007\/s12011-016-0784-2","volume":"175","author":"IA Adedara","year":"2017","unstructured":"Adedara IA, Ojuade TJ, Olabiyi BF, Idris UF, Onibiyo EM, Ajeigbe OF, Farombi EO (2017) Taurine ameliorates renal oxidative damage and thyroid dysfunction in rats chronically exposed to fluoride. Biol Trace Elem Res 175(2):388\u2013395","journal-title":"Biol Trace Elem Res"},{"key":"95_CR3","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1097\/00062752-199603010-00013","volume":"3","author":"S Akira","year":"1996","unstructured":"Akira S, Kishimoto T (1996) Role of interleukin-6 in macrophage function. Curr Opin Hematol 3:87\u201393","journal-title":"Curr Opin Hematol"},{"key":"95_CR4","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/390238","volume":"2011","author":"S Ayla","year":"2011","unstructured":"Ayla S, Seckin I, Tanriverdi G, Cengiz M, Eser M, Soner BC, Oktem G (2011) Doxorubicin induced nephrotoxicity: protective effect of nicotinamide. Int J Cell Biol 2011:Article ID 390238","journal-title":"Int J Cell Biol"},{"key":"95_CR5","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.jjcc.2011.01.007","volume":"57","author":"MR Beyranvand","year":"2011","unstructured":"Beyranvand MR, Khalafi MK, Roshan VD, Choobineh S, Parsa SA, Piranfar MA (2011) Effect of taurine supplementation on exercise capacity of patients with heart failure. J Cardiol 57:333\u2013337","journal-title":"J Cardiol"},{"key":"95_CR6","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1177\/019262339402200502","volume":"22","author":"CR Comereski","year":"1994","unstructured":"Comereski CR, Peden WM, Davidson TJ, Warner GL, Hirth RS, Frantz JD (1994) BR96-doxorubicin conjugate (BMS-182248) versus doxorubicin: a comparative toxicity assessment in rats. Toxicol Pathol 22:473\u2013488","journal-title":"Toxicol Pathol"},{"key":"95_CR7","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1186\/s12967-015-0610-1","volume":"13","author":"A De Luca","year":"2015","unstructured":"De Luca A, Pierno S, Camerino DC (2015) Taurine: the appeal of a safe amino acidfor skeletal muscle disorders. J Transl Med 13:243","journal-title":"J Transl Med"},{"key":"95_CR8","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1093\/ndt\/16.1.147","volume":"16","author":"A Deman","year":"2001","unstructured":"Deman A, Ceyssens B, Pauwels M, Zhang J, Houte KV, Verbeelen D, Van den Branden C (2001) Altered antioxidant defence in a mouse adriamycin model of glomerulosclerosis. Nephrol Dial Transplant 16:147\u2013150","journal-title":"Nephrol Dial Transplant"},{"key":"95_CR9","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/S0006-2952(98)00307-4","volume":"57","author":"DA Gewirtz","year":"1999","unstructured":"Gewirtz DA (1999) A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin. Biochem Pharmacol 57:727\u2013741","journal-title":"Biochem Pharmacol"},{"key":"95_CR10","first-page":"72","volume":"25","author":"MA Grenier","year":"1998","unstructured":"Grenier MA, Lipshultz SE (1998) Epidemiology of anthracycline cardiotoxicity in children and adults. Semin Oncol 25:72\u201385","journal-title":"Semin Oncol"},{"key":"95_CR11","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1002\/jbt.21570","volume":"28","author":"MH Hassan","year":"2014","unstructured":"Hassan MH, Ghobara M, Abd-Allah GM (2014) Modulator effects of meloxicam against doxorubicin-induced nephrotoxicity in mice. J Biochem Mol Toxicol 28:337\u2013346","journal-title":"J Biochem Mol Toxicol"},{"key":"95_CR12","first-page":"181","volume":"715","author":"S Honma","year":"2013","unstructured":"Honma S, Takahashi N, Shinohara M, Nakamura K, Mitazaki S, Abe S, Yoshida M (2013) Amelioration of cisplatin- induced mouse renal lesions by acyclooxygenase (COX)-2 selective inhibitor. Eur J P harmacol 715:181\u2013188","journal-title":"Eur J P harmacol"},{"key":"95_CR13","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s00726-013-1507-z","volume":"46","author":"T Ito","year":"2014","unstructured":"Ito T, Schaffer S, Azuma J (2014) The effect of taurine on chronic heart failure: actions of taurine against catecholamine and angiotensin II. Amino Acids 46:111\u2013119","journal-title":"Amino Acids"},{"key":"95_CR14","first-page":"569","volume-title":"Cancer medicine","year":"2003","unstructured":"Kufe DW, Pollock RE, Weichselbaum RR, Bast RC, Gansler TS, Holland JF, Frei E III (eds) (2003) Cancer medicine, 6th edn. BC Decker, Hamilton, pp 569\u2013583","edition":"6"},{"key":"95_CR15","first-page":"713","volume":"7","author":"G Mazue","year":"1995","unstructured":"Mazue G, Iatropoulos M, Imondi A, Castellino S, Brughera M, Podesta A, Dellatorre P, Moneta D (1995) Anthracyclines\u2014a review of general and special toxicity studies. Int J Oncol 7:713\u2013726","journal-title":"Int J Oncol"},{"key":"95_CR16","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1093\/ndt\/gfn596","volume":"24","author":"N Mihailovic-Stanojevic","year":"2009","unstructured":"Mihailovic-Stanojevic N, Jovovic D, Miloradovic Z, Grujic-Milanovic J, Jerkic M, Markovic-Lipkovski J (2009) Reduced progression of adriamycin nephropathy in spontaneously hypertensive rats treated by losartan. Nephrol Dial Transplant 24:1142\u20131150","journal-title":"Nephrol Dial Transplant"},{"key":"95_CR17","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1124\/pr.56.2.6","volume":"56","author":"G Minotti","year":"2004","unstructured":"Minotti G, Menna P, Salvatorelli E, Cairo G, Gianni L (2004) Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol Rev 56:185\u2013229","journal-title":"Pharmacol Rev"},{"key":"95_CR18","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.brainresbull.2011.07.001","volume":"86","author":"RH Mohamed","year":"2011","unstructured":"Mohamed RH, Karam RA, Amer MG (2011) Epicatechin attenuates doxorubicin-induced brain toxicity: Critical role of TNF-alpha, iNOS and NF-kappaB. Brain Res Bull 86:22\u201328","journal-title":"Brain Res Bull"},{"key":"95_CR19","first-page":"887","volume":"23","author":"M Nukatsuka","year":"1996","unstructured":"Nukatsuka M, Fujioka A, Saito H, Uchida J, Takeda S, Unemi N (1996) Prolongation of survival and antitumor activity of antitumor drugs in murine cancer cachexia model. Gan To Kagaku Ryoho 23:887\u2013892","journal-title":"Gan To Kagaku Ryoho"},{"key":"95_CR20","first-page":"8","volume":"50","author":"SS Oja","year":"2007","unstructured":"Oja SS, Saransaari P (2007) Pharmacology of taurine. Proc West Pharmacol Soc 50:8\u201315","journal-title":"Proc West Pharmacol Soc"},{"key":"95_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0041439","volume":"7","author":"MC Pansani","year":"2012","unstructured":"Pansani MC, Azevedo PS, Rafacho BP, Minicucci MF, Chiuso-Minicucci F, Zorzella-Pezavento SG, Marchini JS, Padovan GJ, Fernandes AA, Matsubara BB, Matsubara LS, Zornoff LA, Paiva SA (2012) Atrophic cardiac remodeling induced by taurine deficiency in Wistar rats. PLoS One 7:e41439","journal-title":"PLoS One"},{"key":"95_CR22","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1093\/annonc\/mdn292","volume":"19","author":"D Rayson","year":"2008","unstructured":"Rayson D, Richel D, Chia S, Jackisch C, van der Vegt S, Suter T (2008) Anthracycline-trastuzumab regimens for HER2\/neu-overexpressing breast cancer: current experience andfuture strategies. Ann Oncol 19:1530\u20131539","journal-title":"Ann Oncol"},{"key":"95_CR23","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.prostaglandins.2011.11.004","volume":"98","author":"A Rios","year":"2012","unstructured":"Rios A, Vargas-Robles H, Gamez-Mendez AM, Escalante B (2012) Cyclooxygenase-2 and kidney failure. Prostaglandins Other Lipid Mediat 98:86\u201390","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"95_CR24","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1007\/s00394-013-0586-7","volume":"53","author":"FT Rosa","year":"2014","unstructured":"Rosa FT, Freitas EC, Deminice R, Jord\u00e3o AA, Marchini JS (2014) Oxidative stress and inflammation in obesity after taurine supplementation: a double-blind, placebo-controlled study. Eur J Nutr 53:823\u2013830","journal-title":"Eur J Nutr"},{"key":"95_CR25","doi-asserted-by":"publisher","first-page":"96","DOI":"10.4172\/1948-5956.1000068","volume":"3","author":"AN Shafik","year":"2011","unstructured":"Shafik AN, Khodeir MM, Fadel MS (2011) Animal study of anthracycline-induced cardiotoxicity and nephrotoxicity and evaluation of protective agents. J Cancer Sci Ther 3:96\u2013103","journal-title":"J Cancer Sci Ther"},{"key":"95_CR26","doi-asserted-by":"publisher","first-page":"e54","DOI":"10.1159\/000084655","volume":"100","author":"Y Shima","year":"2005","unstructured":"Shima Y, Iwano M, Yoshizaki K, Tanaka T, Kawase I, Nishimoto N (2005) All-trans-retinoic acid inhibits the development of mesangial proliferative glomerulonephritis in interleukin-6 transgenic mice. Nephron Exp Nephrol 100:e54\u2013e62","journal-title":"Nephron Exp Nephrol"},{"key":"95_CR27","first-page":"2892","volume":"44","author":"BK Sinha","year":"1984","unstructured":"Sinha BK, Trush MA, Kennedy KA, Mimnaugh EG (1984) Enzymatic activation and binding of adriamycin to nuclear DNA. Cancer Res 44:2892\u20132896","journal-title":"Cancer Res"},{"key":"95_CR28","doi-asserted-by":"publisher","first-page":"7547","DOI":"10.1073\/pnas.86.19.7547","volume":"86","author":"S Suematsu","year":"1989","unstructured":"Suematsu S, Matsuda T, Aozasa K, Akira S, Nakano N, Ohno S, Miyazaki J, Yamamura K, Hirano T, Kishimoto T (1989) Igg1 plasmacytosis in interleukin 6 transgenic mice. Proc Natl Acad Sci U S A 86:7547\u20137551","journal-title":"Proc Natl Acad Sci U S A"},{"key":"95_CR29","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s12011-011-9273-9","volume":"147","author":"E Taskin","year":"2012","unstructured":"Taskin E, Dursun N (2012) The protection of selenium on adriamycin-induced mitochondrial damage in rat. Biol Trace Elem Res 147:165\u2013171","journal-title":"Biol Trace Elem Res"},{"key":"95_CR31","doi-asserted-by":"publisher","first-page":"F679","DOI":"10.1152\/ajprenal.90680.2008","volume":"297","author":"M Tomiyama-Hanayama","year":"2009","unstructured":"Tomiyama-Hanayama M, Rakugi H, Kohara M, Mima T, Adachi Y, Ohishi M, Katsuya T, Hoshida Y, Aozasa K, Ogihara T, Nishimoto N (2009) Effect of interleukin-6 receptor blockage on renal injury in apolipoprotein E-deficient mice. Am J Physiol Renal Physiol 297:F679\u2013F684","journal-title":"Am J Physiol Renal Physiol"},{"key":"95_CR32","first-page":"90","volume-title":"Cardiotoxicity of oncologic treatments","author":"VM Torres","year":"2012","unstructured":"Torres VM, Simic VD (2012) Doxorubicin-induced oxidative injury of cardiomyocytes\u2014do we have right strategies for prevention? In: Fiuza M (ed) Cardiotoxicity of oncologic treatments. Intech, Rijeka, pp 90\u2013130"},{"key":"95_CR33","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s00262-003-0391-x","volume":"52","author":"P Ujhazy","year":"2003","unstructured":"Ujhazy P, Zaleskis G, Mihich E, Ehrke MJ, Berleth ES (2003) Doxorubicin induces specific immune functions and cytokine expression in peritoneal cells. Cancer Immunol Immunother 52:463\u2013472","journal-title":"Cancer Immunol Immunother"},{"key":"95_CR34","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1159\/000057614","volume":"91","author":"C Van den Branden","year":"2002","unstructured":"Van den Branden C, Deman A, Ceyssens B, Pauwels M, Empsen C, Verbeelen D (2002) Vitamin E protects renal antioxidant enzymes and attenuates glomerulosclerosis in adriamycin-treated rats. Nephron 91:129\u2013133","journal-title":"Nephron"},{"key":"95_CR35","doi-asserted-by":"publisher","first-page":"214","DOI":"10.2174\/157340311799960645","volume":"7","author":"M Volkova","year":"2011","unstructured":"Volkova M, Russell R (2011) Anthracycline cardiotoxicity: prevalence, pathogenesis and treatment. Curr Cardiol Rev 7:214\u2013220","journal-title":"Curr Cardiol Rev"},{"key":"95_CR36","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3325\/cmj.2013.54.171","volume":"54","author":"GG Wang","year":"2013","unstructured":"Wang GG, Li W, Lu XH, Zhao X, Xu L (2013) Taurine attenuates oxidative stress and alleviates cardiac failure in type I diabetic rats. Croat Med J 54:171\u2013179","journal-title":"Croat Med J"},{"key":"95_CR37","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1046\/j.1523-1755.2000.00342.x","volume":"58","author":"Y Wang","year":"2000","unstructured":"Wang Y, Wang YP, Tay Y, Harris DC (2000) Progressive adriamycin nephropathy in mice: sequence of histologic and immunohistochemical events. Kidney Int 58:1797\u20131804","journal-title":"Kidney Int"},{"key":"95_CR38","doi-asserted-by":"publisher","first-page":"12563","DOI":"10.1038\/srep12563","volume":"5","author":"Y Zhang","year":"2015","unstructured":"Zhang Y, Tao L, Fan L, Peng Y, Yang K, Zhao Y, Song Q, Wanga Q (2015) Different gap junction-propagated effects on cisplatin transfer result in opposite responses to cisplatin in normal cells versus tumor cells. Sci Rep 5:12563","journal-title":"Sci Rep"},{"key":"95_CR39","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.brainresbull.2016.06.010","volume":"124","author":"XY Zhu","year":"2016","unstructured":"Zhu XY, Ma PS, Wu W, Zhou R, Hao YJ, Niu Y, Sun T, Li YX, Yu JQ (2016) Neuroprotective actions of taurine on hypoxic-ischemic brain damage in neonatal rats. Brain Res Bull 124:295\u2013305","journal-title":"Brain Res Bull"}],"container-title":["Advances in Experimental Medicine and Biology","Taurine 10"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-94-024-1079-2_95","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,5]],"date-time":"2024-03-05T13:22:03Z","timestamp":1709644923000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-94-024-1079-2_95"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"ISBN":["9789402410778","9789402410792"],"references-count":38,"URL":"https:\/\/doi.org\/10.1007\/978-94-024-1079-2_95","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}